Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression

Fig. 1

Predictive values of immune cell levels in progress of lung cancer. Distribution of B cell counts (a), NK cell counts (b), CD4+ T cell counts (c), naïve CD4+/CD4+ percentage, (d) naïve CD4+ T counts (e), CD4+CD28+ T counts (f), CD8+CD28+ T counts (g), WBC counts (h), monocytes counts (i), neutrophils counts (j), eosinophils counts (k), basophils counts (l), MLR (m), NLR (n), ELR (o), BLR (p), PLR (q)

Back to article page